Concepts (283)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Citrulline | 9 | 2024 | 114 | 2.570 |
Why?
|
| Lactation | 9 | 2020 | 200 | 2.270 |
Why?
|
| Arginine | 8 | 2024 | 350 | 2.240 |
Why?
|
| Milk, Human | 9 | 2022 | 311 | 2.050 |
Why?
|
| Mammary Glands, Human | 4 | 2015 | 84 | 1.340 |
Why?
|
| Polyethylene Glycols | 3 | 2024 | 257 | 0.850 |
Why?
|
| Arginase | 2 | 2020 | 35 | 0.820 |
Why?
|
| Galactose | 2 | 2015 | 57 | 0.810 |
Why?
|
| Hydrolases | 3 | 2024 | 61 | 0.780 |
Why?
|
| Glutamine | 3 | 2024 | 222 | 0.700 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2020 | 261 | 0.670 |
Why?
|
| Jejunum | 1 | 2020 | 131 | 0.660 |
Why?
|
| Glucose | 5 | 2015 | 927 | 0.650 |
Why?
|
| Duodenum | 1 | 2020 | 110 | 0.650 |
Why?
|
| Swine | 8 | 2024 | 1219 | 0.650 |
Why?
|
| Amino Acids | 2 | 2024 | 687 | 0.610 |
Why?
|
| Gluconeogenesis | 3 | 2015 | 111 | 0.590 |
Why?
|
| Nutrigenomics | 1 | 2017 | 9 | 0.570 |
Why?
|
| Glycerol | 2 | 2015 | 99 | 0.540 |
Why?
|
| Aging | 2 | 2024 | 1306 | 0.510 |
Why?
|
| Lactose | 2 | 2020 | 56 | 0.500 |
Why?
|
| Gastrointestinal Tract | 1 | 2018 | 243 | 0.500 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2020 | 1050 | 0.490 |
Why?
|
| Blood Glucose | 5 | 2024 | 1195 | 0.490 |
Why?
|
| Intestinal Mucosa | 1 | 2020 | 816 | 0.470 |
Why?
|
| Lipids | 3 | 2013 | 566 | 0.470 |
Why?
|
| Lipogenesis | 2 | 2021 | 59 | 0.470 |
Why?
|
| Metabolic Networks and Pathways | 3 | 2018 | 196 | 0.420 |
Why?
|
| Lipid Metabolism | 2 | 2020 | 388 | 0.410 |
Why?
|
| Triglycerides | 3 | 2019 | 617 | 0.410 |
Why?
|
| Dietary Carbohydrates | 2 | 2014 | 117 | 0.400 |
Why?
|
| MicroRNAs | 2 | 2017 | 951 | 0.400 |
Why?
|
| Uridine Diphosphate Galactose | 1 | 2012 | 6 | 0.390 |
Why?
|
| Fasting | 2 | 2014 | 308 | 0.380 |
Why?
|
| Female | 28 | 2024 | 71863 | 0.360 |
Why?
|
| Oligosaccharides | 2 | 2022 | 78 | 0.350 |
Why?
|
| Diabetes, Gestational | 1 | 2012 | 115 | 0.350 |
Why?
|
| Insulin | 3 | 2010 | 1260 | 0.350 |
Why?
|
| Dietary Sucrose | 1 | 2010 | 42 | 0.340 |
Why?
|
| Animals | 21 | 2024 | 36538 | 0.330 |
Why?
|
| Epithelial Cells | 2 | 2020 | 937 | 0.330 |
Why?
|
| Breast Feeding | 3 | 2020 | 245 | 0.330 |
Why?
|
| Vitamin B 12 | 2 | 2007 | 63 | 0.330 |
Why?
|
| Cholestasis | 2 | 2021 | 157 | 0.300 |
Why?
|
| Caloric Restriction | 1 | 2009 | 91 | 0.300 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2024 | 1416 | 0.290 |
Why?
|
| Hymenolepiasis | 1 | 2007 | 1 | 0.290 |
Why?
|
| Hymenolepis nana | 1 | 2007 | 1 | 0.290 |
Why?
|
| Insulin Resistance | 3 | 2024 | 700 | 0.290 |
Why?
|
| Gene Expression Regulation | 3 | 2014 | 2666 | 0.280 |
Why?
|
| Folic Acid | 2 | 2007 | 298 | 0.280 |
Why?
|
| Animals, Newborn | 3 | 2020 | 1044 | 0.280 |
Why?
|
| Nutritional Status | 2 | 2020 | 325 | 0.280 |
Why?
|
| Dietary Fats | 1 | 2009 | 300 | 0.270 |
Why?
|
| Mice, Inbred C57BL | 6 | 2024 | 4877 | 0.270 |
Why?
|
| Lactobacillus acidophilus | 1 | 2006 | 2 | 0.270 |
Why?
|
| Intestinal Absorption | 1 | 2007 | 193 | 0.270 |
Why?
|
| Methylmalonic Acid | 1 | 2006 | 15 | 0.260 |
Why?
|
| Neuroblastoma | 2 | 2022 | 550 | 0.260 |
Why?
|
| Homocysteine | 1 | 2006 | 120 | 0.250 |
Why?
|
| Social Class | 1 | 2007 | 210 | 0.250 |
Why?
|
| Fatty Acids | 2 | 2022 | 372 | 0.250 |
Why?
|
| Probiotics | 2 | 2020 | 229 | 0.250 |
Why?
|
| Growth Disorders | 1 | 2007 | 224 | 0.240 |
Why?
|
| Male | 17 | 2024 | 66066 | 0.240 |
Why?
|
| Infusions, Intravenous | 2 | 2018 | 572 | 0.240 |
Why?
|
| Weight Loss | 1 | 2009 | 516 | 0.230 |
Why?
|
| Receptors, Adrenergic, beta-3 | 1 | 2024 | 13 | 0.230 |
Why?
|
| N-Myc Proto-Oncogene Protein | 2 | 2022 | 65 | 0.230 |
Why?
|
| Population Surveillance | 1 | 2007 | 419 | 0.230 |
Why?
|
| Obesity | 3 | 2024 | 2446 | 0.230 |
Why?
|
| Thermogenesis | 1 | 2024 | 52 | 0.220 |
Why?
|
| Kinetics | 2 | 2021 | 1357 | 0.220 |
Why?
|
| Carbon Isotopes | 2 | 2015 | 279 | 0.220 |
Why?
|
| Adipose Tissue, Brown | 1 | 2024 | 87 | 0.220 |
Why?
|
| Endotoxemia | 1 | 2024 | 56 | 0.210 |
Why?
|
| Adipose Tissue, White | 1 | 2024 | 93 | 0.210 |
Why?
|
| Adult | 11 | 2024 | 31922 | 0.210 |
Why?
|
| Parenteral Nutrition | 3 | 2021 | 199 | 0.210 |
Why?
|
| Energy Metabolism | 2 | 2024 | 814 | 0.210 |
Why?
|
| Biological Availability | 2 | 2021 | 153 | 0.210 |
Why?
|
| Kidney | 2 | 2019 | 1421 | 0.190 |
Why?
|
| Glycomics | 1 | 2021 | 16 | 0.180 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 1 | 1 | 2021 | 18 | 0.180 |
Why?
|
| Biosynthetic Pathways | 1 | 2021 | 28 | 0.180 |
Why?
|
| Phytosterols | 1 | 2021 | 29 | 0.180 |
Why?
|
| Humans | 25 | 2024 | 134040 | 0.170 |
Why?
|
| Propane | 1 | 2020 | 28 | 0.170 |
Why?
|
| Glyceraldehyde | 1 | 2020 | 28 | 0.170 |
Why?
|
| Gene Expression Profiling | 4 | 2017 | 1922 | 0.170 |
Why?
|
| Polysaccharides | 1 | 2021 | 152 | 0.170 |
Why?
|
| Urea Cycle Disorders, Inborn | 2 | 2020 | 85 | 0.170 |
Why?
|
| Liver Glycogen | 1 | 2020 | 23 | 0.170 |
Why?
|
| Tissue Distribution | 1 | 2021 | 402 | 0.170 |
Why?
|
| Metagenome | 1 | 2020 | 158 | 0.160 |
Why?
|
| Argininosuccinate Lyase | 1 | 2020 | 65 | 0.160 |
Why?
|
| Diet | 3 | 2020 | 1195 | 0.160 |
Why?
|
| Synbiotics | 1 | 2019 | 5 | 0.150 |
Why?
|
| Nitrogen Isotopes | 1 | 2018 | 63 | 0.150 |
Why?
|
| Ornithine Carbamoyltransferase | 1 | 2018 | 17 | 0.150 |
Why?
|
| Docosahexaenoic Acids | 1 | 2019 | 68 | 0.150 |
Why?
|
| Dipeptides | 1 | 2018 | 64 | 0.150 |
Why?
|
| Endotoxins | 1 | 2018 | 50 | 0.140 |
Why?
|
| Liver Diseases, Alcoholic | 1 | 2019 | 59 | 0.140 |
Why?
|
| Oxidation-Reduction | 2 | 2009 | 470 | 0.140 |
Why?
|
| Microbiota | 2 | 2020 | 443 | 0.140 |
Why?
|
| Intestinal Diseases | 1 | 2019 | 87 | 0.140 |
Why?
|
| Helicobacter pylori | 1 | 2007 | 1335 | 0.140 |
Why?
|
| Helicobacter Infections | 1 | 2007 | 1278 | 0.140 |
Why?
|
| Benzoates | 1 | 2017 | 23 | 0.140 |
Why?
|
| Disease Models, Animal | 3 | 2024 | 4806 | 0.140 |
Why?
|
| Bile Acids and Salts | 1 | 2020 | 259 | 0.140 |
Why?
|
| Ethanol | 1 | 2019 | 170 | 0.140 |
Why?
|
| Reactive Oxygen Species | 1 | 2020 | 535 | 0.140 |
Why?
|
| Egypt | 2 | 2007 | 29 | 0.140 |
Why?
|
| Lactic Acid | 2 | 2015 | 166 | 0.140 |
Why?
|
| Phenylbutyrates | 1 | 2017 | 58 | 0.130 |
Why?
|
| Mice | 8 | 2024 | 19043 | 0.130 |
Why?
|
| Biological Transport | 2 | 2021 | 371 | 0.130 |
Why?
|
| Growth | 1 | 2017 | 106 | 0.130 |
Why?
|
| Mice, Knockout | 3 | 2020 | 4013 | 0.130 |
Why?
|
| Transcriptome | 2 | 2014 | 1137 | 0.130 |
Why?
|
| Models, Animal | 1 | 2018 | 486 | 0.130 |
Why?
|
| Nutritional Requirements | 1 | 2017 | 180 | 0.130 |
Why?
|
| Enteral Nutrition | 1 | 2018 | 268 | 0.130 |
Why?
|
| Liver Diseases | 1 | 2020 | 392 | 0.120 |
Why?
|
| Premature Birth | 1 | 2020 | 418 | 0.120 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 2015 | 32 | 0.120 |
Why?
|
| Cross-Over Studies | 2 | 2020 | 331 | 0.120 |
Why?
|
| Sex Characteristics | 1 | 2017 | 338 | 0.120 |
Why?
|
| Sodium Acetate | 1 | 2015 | 2 | 0.120 |
Why?
|
| Pentose Phosphate Pathway | 1 | 2015 | 44 | 0.120 |
Why?
|
| Nitric Oxide | 1 | 2018 | 490 | 0.120 |
Why?
|
| Isotope Labeling | 2 | 2018 | 106 | 0.110 |
Why?
|
| Genotype | 1 | 2020 | 2808 | 0.110 |
Why?
|
| Intestines | 1 | 2018 | 614 | 0.110 |
Why?
|
| Pyruvate Kinase | 1 | 2014 | 11 | 0.110 |
Why?
|
| Genes, Lethal | 1 | 2014 | 77 | 0.110 |
Why?
|
| Blood Chemical Analysis | 1 | 2014 | 88 | 0.100 |
Why?
|
| Infant, Premature | 1 | 2019 | 858 | 0.100 |
Why?
|
| Fatty Liver | 1 | 2015 | 215 | 0.100 |
Why?
|
| Pulmonary Alveoli | 1 | 2014 | 142 | 0.100 |
Why?
|
| Research Design | 1 | 2017 | 747 | 0.100 |
Why?
|
| Persistent Fetal Circulation Syndrome | 1 | 2014 | 90 | 0.100 |
Why?
|
| Stromal Cells | 1 | 2014 | 313 | 0.100 |
Why?
|
| Metabolism | 1 | 2012 | 45 | 0.100 |
Why?
|
| Pulmonary Veins | 1 | 2014 | 167 | 0.100 |
Why?
|
| Diet, High-Fat | 1 | 2014 | 241 | 0.100 |
Why?
|
| Pregnancy | 3 | 2019 | 7570 | 0.090 |
Why?
|
| Forkhead Transcription Factors | 1 | 2014 | 389 | 0.090 |
Why?
|
| Microarray Analysis | 1 | 2012 | 239 | 0.090 |
Why?
|
| Eating | 1 | 2014 | 395 | 0.090 |
Why?
|
| Hormones | 1 | 2012 | 198 | 0.090 |
Why?
|
| Estradiol | 1 | 2014 | 559 | 0.090 |
Why?
|
| Protein Carbonylation | 1 | 2010 | 8 | 0.090 |
Why?
|
| Palmitic Acid | 1 | 2010 | 33 | 0.090 |
Why?
|
| Young Adult | 2 | 2017 | 9929 | 0.090 |
Why?
|
| Infant | 4 | 2022 | 13220 | 0.090 |
Why?
|
| Lipid Peroxidation | 1 | 2010 | 98 | 0.090 |
Why?
|
| Anti-Obesity Agents | 1 | 2010 | 45 | 0.090 |
Why?
|
| Prevalence | 2 | 2007 | 2684 | 0.080 |
Why?
|
| Emulsions | 2 | 2021 | 70 | 0.080 |
Why?
|
| Estrogen Receptor alpha | 1 | 2014 | 475 | 0.080 |
Why?
|
| Single-Blind Method | 1 | 2010 | 250 | 0.080 |
Why?
|
| Soybean Oil | 2 | 2021 | 71 | 0.080 |
Why?
|
| Fish Oils | 2 | 2021 | 84 | 0.080 |
Why?
|
| Hexoses | 1 | 2009 | 11 | 0.080 |
Why?
|
| Ketone Bodies | 1 | 2009 | 49 | 0.080 |
Why?
|
| Calorimetry, Indirect | 1 | 2009 | 61 | 0.080 |
Why?
|
| Lactates | 1 | 2009 | 102 | 0.080 |
Why?
|
| Glucagon | 1 | 2009 | 184 | 0.080 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2009 | 139 | 0.080 |
Why?
|
| C-Peptide | 1 | 2009 | 116 | 0.080 |
Why?
|
| Nuclear Proteins | 1 | 2015 | 1343 | 0.080 |
Why?
|
| Diet, Reducing | 1 | 2009 | 94 | 0.070 |
Why?
|
| Mannitol | 1 | 2007 | 49 | 0.070 |
Why?
|
| Lactulose | 1 | 2007 | 43 | 0.070 |
Why?
|
| Permeability | 1 | 2007 | 131 | 0.070 |
Why?
|
| Dietary Proteins | 1 | 2009 | 252 | 0.070 |
Why?
|
| Urea | 2 | 2018 | 238 | 0.070 |
Why?
|
| Breath Tests | 1 | 2007 | 186 | 0.070 |
Why?
|
| Yogurt | 1 | 2006 | 13 | 0.070 |
Why?
|
| Models, Biological | 1 | 2012 | 1539 | 0.070 |
Why?
|
| Vitamin B 12 Deficiency | 1 | 2006 | 45 | 0.060 |
Why?
|
| Energy Intake | 1 | 2009 | 518 | 0.060 |
Why?
|
| Body Height | 1 | 2007 | 230 | 0.060 |
Why?
|
| Texas | 1 | 2015 | 3715 | 0.060 |
Why?
|
| Lung | 1 | 2014 | 1575 | 0.060 |
Why?
|
| Liver | 3 | 2019 | 1879 | 0.060 |
Why?
|
| Adolescent | 3 | 2024 | 20603 | 0.060 |
Why?
|
| Chi-Square Distribution | 1 | 2006 | 606 | 0.060 |
Why?
|
| Transcription Factors | 1 | 2015 | 2729 | 0.060 |
Why?
|
| Adrenergic beta-3 Receptor Agonists | 1 | 2024 | 6 | 0.060 |
Why?
|
| Dioxoles | 1 | 2024 | 11 | 0.060 |
Why?
|
| Uncoupling Protein 1 | 1 | 2024 | 32 | 0.060 |
Why?
|
| Promoter Regions, Genetic | 2 | 2021 | 1433 | 0.060 |
Why?
|
| Mutation | 1 | 2018 | 6306 | 0.060 |
Why?
|
| Oxidative Stress | 2 | 2020 | 877 | 0.060 |
Why?
|
| Cell Line, Tumor | 2 | 2022 | 3796 | 0.050 |
Why?
|
| Amino Acids, Branched-Chain | 1 | 2024 | 82 | 0.050 |
Why?
|
| Body Weight | 1 | 2007 | 1041 | 0.050 |
Why?
|
| Glutamic Acid | 1 | 2024 | 209 | 0.050 |
Why?
|
| Dietary Supplements | 1 | 2006 | 489 | 0.050 |
Why?
|
| Lipopolysaccharides | 1 | 2024 | 319 | 0.050 |
Why?
|
| Child | 3 | 2007 | 25858 | 0.050 |
Why?
|
| Gene Expression | 2 | 2019 | 1621 | 0.050 |
Why?
|
| Sex Factors | 2 | 2017 | 1387 | 0.050 |
Why?
|
| Glycosyltransferases | 1 | 2022 | 27 | 0.050 |
Why?
|
| Algorithms | 1 | 2009 | 1735 | 0.050 |
Why?
|
| Fucosyltransferases | 1 | 2021 | 30 | 0.050 |
Why?
|
| ARNTL Transcription Factors | 1 | 2021 | 42 | 0.050 |
Why?
|
| Glycosylation | 1 | 2021 | 128 | 0.040 |
Why?
|
| Mucins | 1 | 2021 | 77 | 0.040 |
Why?
|
| Gene Knockout Techniques | 1 | 2021 | 139 | 0.040 |
Why?
|
| Spores, Bacterial | 1 | 2020 | 24 | 0.040 |
Why?
|
| Gangliosides | 1 | 2021 | 73 | 0.040 |
Why?
|
| Benzamides | 1 | 2021 | 125 | 0.040 |
Why?
|
| Erythropoietin | 1 | 2021 | 110 | 0.040 |
Why?
|
| Fat Emulsions, Intravenous | 1 | 2021 | 78 | 0.040 |
Why?
|
| Drug Synergism | 1 | 2020 | 242 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2007 | 3666 | 0.040 |
Why?
|
| Cluster Analysis | 1 | 2021 | 440 | 0.040 |
Why?
|
| Alanine Transaminase | 1 | 2020 | 162 | 0.040 |
Why?
|
| Olive Oil | 1 | 2019 | 24 | 0.040 |
Why?
|
| Fatty Liver, Alcoholic | 1 | 2019 | 2 | 0.040 |
Why?
|
| Tight Junction Proteins | 1 | 2019 | 14 | 0.040 |
Why?
|
| Fatty Acid Transport Proteins | 1 | 2019 | 11 | 0.040 |
Why?
|
| Aldehydes | 1 | 2019 | 32 | 0.040 |
Why?
|
| Fermentation | 1 | 2019 | 71 | 0.040 |
Why?
|
| Cell Survival | 1 | 2021 | 890 | 0.040 |
Why?
|
| Fatty Acids, Volatile | 1 | 2019 | 47 | 0.040 |
Why?
|
| Ornithine Carbamoyltransferase Deficiency Disease | 1 | 2018 | 35 | 0.040 |
Why?
|
| Argininosuccinate Synthase | 1 | 2018 | 25 | 0.040 |
Why?
|
| Tissue Culture Techniques | 1 | 2018 | 68 | 0.040 |
Why?
|
| Vasomotor System | 1 | 2018 | 21 | 0.040 |
Why?
|
| Mice, Inbred ICR | 1 | 2018 | 153 | 0.040 |
Why?
|
| Cross-Sectional Studies | 1 | 2007 | 3754 | 0.040 |
Why?
|
| Cytokines | 1 | 2024 | 1400 | 0.040 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2021 | 1011 | 0.040 |
Why?
|
| Mice, Mutant Strains | 1 | 2018 | 400 | 0.030 |
Why?
|
| Dysbiosis | 1 | 2019 | 145 | 0.030 |
Why?
|
| Organoids | 1 | 2020 | 299 | 0.030 |
Why?
|
| Weaning | 1 | 2017 | 51 | 0.030 |
Why?
|
| Nitrogen | 1 | 2017 | 148 | 0.030 |
Why?
|
| Healthy Volunteers | 1 | 2017 | 153 | 0.030 |
Why?
|
| Inflammation | 1 | 2024 | 1594 | 0.030 |
Why?
|
| Random Allocation | 1 | 2017 | 449 | 0.030 |
Why?
|
| Body Composition | 1 | 2019 | 562 | 0.030 |
Why?
|
| Colon | 1 | 2019 | 379 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2019 | 703 | 0.030 |
Why?
|
| Diet, Western | 1 | 2015 | 17 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2020 | 1506 | 0.030 |
Why?
|
| Carbohydrate Metabolism | 1 | 2015 | 58 | 0.030 |
Why?
|
| Chronic Disease | 1 | 2020 | 1249 | 0.030 |
Why?
|
| Feces | 1 | 2019 | 789 | 0.030 |
Why?
|
| Mitogens | 1 | 2014 | 32 | 0.030 |
Why?
|
| Primary Cell Culture | 1 | 2014 | 110 | 0.030 |
Why?
|
| Infant, Newborn | 2 | 2019 | 8609 | 0.030 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2015 | 189 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2015 | 1140 | 0.030 |
Why?
|
| Oxygen Consumption | 1 | 2014 | 317 | 0.020 |
Why?
|
| Risk Factors | 1 | 2007 | 11179 | 0.020 |
Why?
|
| Weight Gain | 1 | 2015 | 413 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 1331 | 0.020 |
Why?
|
| Cellular Reprogramming | 1 | 2014 | 136 | 0.020 |
Why?
|
| Adipose Tissue | 1 | 2015 | 510 | 0.020 |
Why?
|
| Heterozygote | 1 | 2014 | 722 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2007 | 14858 | 0.020 |
Why?
|
| Alternative Splicing | 1 | 2014 | 377 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2021 | 1853 | 0.020 |
Why?
|
| Biomarkers | 1 | 2021 | 3434 | 0.020 |
Why?
|
| Estrogens | 1 | 2014 | 525 | 0.020 |
Why?
|
| Endometrium | 1 | 2014 | 289 | 0.020 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2019 | 822 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2006 | 13073 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2015 | 2539 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2020 | 2578 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2014 | 1761 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2013 | 957 | 0.020 |
Why?
|
| Brain | 1 | 2019 | 3219 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2014 | 2561 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2014 | 4933 | 0.010 |
Why?
|
| Middle Aged | 1 | 2017 | 29390 | 0.010 |
Why?
|